IQVIA Holdings Inc
NYSE:IQV

  • LAST PRICE
    201.5200
  • TODAY'S CHANGE (%)
    3.9200 (1.9838%)
  • Bid / Lots
    201.3400/ 6
  • Ask / Lots
    201.5200/ 2
  • Open / Previous Close
    197.0300 / 197.6000
  • Day Range
    196.3300
    202.0500
  • 52 Week Range
    187.6200
    261.7300
  • Volume
    661,908

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
IQV
IQVIA Holdings Inc
35.9B
26.4x
+46.62%
BIIB
Biogen Inc
23.0B
14.4x
-18.14%
REGN
Regeneron Pharmaceuticals Inc
81.8B
18.5x
+10.93%
ICLR
ICON PLC
17.6B
23.9x
+4.68%
MRNA
Moderna Inc
14.7B
-7.1x
---
BNTX
Biontech SE
25.9B
-54.5x
---
As of 2024-11-22

Company Information

IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.

Contact Information

Headquarters
2400 ELLIS ROADDURHAM, NC, United States 27703
Phone
919-998-2000
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer
Ari Bousbib
Chief Financial Officer, Executive Vice President
Ronald Bruehlman
President - Research and Development Solutions
Walter Staub
Executive Vice President, General Counsel, Secretary
Eric Sherbet
Lead Independent Director
John Leonard

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$35.9B
Revenue (TTM)
$15.3B
Shares Outstanding
181.6M
IQVIA Holdings Inc does not pay a dividend.
Beta
1.50
EPS
$7.62
Book Value
$33.67
P/E Ratio
26.4x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
14.1x
Operating Margin
13.52%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.